Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations

Mov Disord. 2007 Jul 30;22(10):1510-1514. doi: 10.1002/mds.21581.

Abstract

We assessed the relations of visual hallucinations (VH) to cardiovascular autonomic dysfunction in patients with Parkinson's disease (PD). The subjects were 37 patients without VH (VH(-)) and 31 with VH (VH(+)). Autonomic function was evaluated on the basis of cardiac 123-radioiodinated metaiodobenzylguanidine (123I-MIBG) uptake and hemodynamic testing with Valsalva maneuver. Systolic blood pressure (SBP) and plasma norepinephrine concentrations (NE) were measured by tilt-table testing. 123I-MIBG uptake was lower in VH(+) than VH(-). Hemodynamic studies showed that VH(-) had only cardiac sympathetic and parasympathetic dysfunction, while VH(+) additionally had reduced vasomotor sympathetic functions. The fall in SBP during tilt-table testing was greater in VH(+) than VH(-). NE and its difference in the supine and upright positions were decreased in VH(+). We conclude that cardiac and vasomotor sympathetic dysfunction is more severe in VH(+) than in VH(-). Severe dysfunction in PD with VH is probably attributed to Lewy-body lesions or neuronal loss in sympathetic ganglia, the central autonomic system, or both.

MeSH terms

  • 3-Iodobenzylguanidine
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Autonomic Nervous System Diseases / diagnostic imaging
  • Autonomic Nervous System Diseases / etiology*
  • Blood Pressure / physiology
  • Cardiovascular Diseases / diagnostic imaging
  • Cardiovascular Diseases / etiology*
  • Female
  • Hallucinations / complications*
  • Humans
  • Male
  • Middle Aged
  • Norepinephrine / blood
  • Parkinson Disease / complications*
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Tilt-Table Test

Substances

  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine
  • Norepinephrine